Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi
05:13 EDT 14 Jun 2012 | thePharmaLetter
As a first critical step of its new strategy to enter into the field of neglected tropical diseases (NTD) drug discovery, Japanese drug major Astellas Pharma (TYO: 4503) has entered into an agreement with the Drugs for Neglected Diseases initiative (..
Original Article: Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi
More From BioPortfolio on "Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
